Physician

Andrew Joseph Sampson, MD

According to 2025 Medicare claims, Andrew Sampson, MD (NPI: 1891911384) practices interventional cardiology in the Raleigh-Cary, NC market, with the plurality of this provider's patient population coming from Wake, NC. This provider's primary affiliated billing organization is WAKEMED SPECIALISTS GROUP, LLC (NPI: 1720643174; TIN: 83-4333066) and primary practice location at 27610-1231. Sampson is affiliated with the Ascension Care Management (ACO ID: A2600) and Main Street Rural Health Cedar ACO LLC (ACO ID: A5502), participating under the MSSP model.

Sampson's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 305 traditional Medicare patients, billed 823 HCPCS/CPT codes, and received $91,411 in Medicare payments. The top billing code was 93458 (Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist). Part D data shows 1,122 prescription claims across 265 beneficiaries totaling $247,460 in drug costs, led by Eliquis (Apixaban). Open Payments data shows 32 records totaling $24,189. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have risen steadily, from $31,091 to $247,460. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	595	1,154	$119,882
2016	486	1,091	$121,597
2017	571	1,326	$130,672
2018	636	1,613	$141,548
2019	667	1,739	$165,688
2020	511	1,168	$115,250
2021	509	1,243	$142,218
2022	473	1,147	$125,257
2023	490	1,210	$128,938
2024	305	823	$91,411

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	135	713	$31,091
2016	190	1,209	$70,651
2017	209	1,401	$100,597
2018	358	2,221	$185,094
2019	387	2,869	$332,955
2020	358	2,443	$347,989
2021	314	2,011	$296,002
2022	338	2,069	$328,681
2023	361	2,154	$435,304
2024	265	1,122	$247,460

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
93458	Insertion of tube in left lower heart chamber and coronary artery for diagnosis with review by radiologist	63	63	$171
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	40	67	$59
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	100	103	$53
99152	Use of a drug to induce depression of consciousness by physician performing a procedure (5 years or older), initial 15 minutes	90	92	$9
93000	Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report	75	78	$6

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	95	6,125	$119,285
Entresto	Sacubitril/Valsartan	27	2,250	$47,988
Repatha Sureclick	Evolocumab	46	1,737	$34,199
Metoprolol Succinate	Metoprolol Succinate	127	10,820	$1,979
Nebivolol Hcl	Nebivolol Hcl	32	2,100	$1,647

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	31	$21,189	Edwards Lifesciences Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	1	$3,000	Medtronic, Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Andrew Joseph Sampson, MD?

Tedicare shows public-source Medicare data for Andrew Joseph Sampson, MD (NPI 1891911384), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Andrew Joseph Sampson, MD have ACO affiliation data?

Andrew Joseph Sampson, MD is shown with ACO affiliation data for Ascension Care Management (MSSP, ACO ID A2600) and Main Street Rural Health Cedar ACO LLC (MSSP, ACO ID A5502).

What billing organization is linked to Andrew Joseph Sampson, MD?

Andrew Joseph Sampson, MD is linked to WAKEMED SPECIALISTS GROUP, LLC (billing NPI 1720643174) in the available physician profile data.

Does Andrew Joseph Sampson, MD have Open Payments data?

Andrew Joseph Sampson, MD has 32 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.